Biolife Solutions INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Casdin Capital, LLC has disclosed an increased beneficial ownership of 9.7% in BioLife Solutions, Inc. following recent share acquisitions.
NASDAQ
Casdin Capital and its affiliates have increased their beneficial ownership in BioLife Solutions, Inc. to 12.4% through a recent share acquisition.
NASDAQ
Casdin Capital and its affiliates have increased their beneficial ownership in BioLife Solutions, Inc. to 14.0% through a recent acquisition of 500,000 shares.
NASDAQ
Casdin Capital, a key investor, has increased its beneficial ownership in BioLife Solutions, Inc. to 15.0% through a recent share acquisition.
NASDAQ
SCHEDULE 13D/A: Casdin Capital Boosts BioLife Solutions Stake to 16.2%, Signals Intent for Shareholder Value Initiatives
Casdin Capital and its affiliates have increased their beneficial ownership in BioLife Solutions, Inc. to 16.2% of outstanding common stock, acquiring an additional 1,000,000 shares, and reserve the right to engage in actions aimed at maximizing shareholder value.
NASDAQ
SCHEDULE 13D/A: Casdin Capital Boosts BioLife Solutions Stake to 18.5% Following PanThera CryoSolutions Acquisition
Casdin Capital, LLC and its affiliates have increased their beneficial ownership in BioLife Solutions, Inc. to 18.5% of outstanding common stock, primarily through shares received in BioLife's acquisition of PanThera CryoSolutions, Inc.